Identifying abuse prevalence in patients with rheumatic diseases
Prevalence of Abuse Among Patients With Rheumatic Diseases
This study is trying to find out how common abuse is among people with rheumatic diseases in Mexico and what factors might be involved.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 244 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | National Institute of Medical Sciences and Nutrition, Salvador Zubiran Academic / other |
| Locations | 1 site (Mexico City) |
| Trial ID | NCT06233760 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prevalence of abuse among patients diagnosed with rheumatic diseases in Mexico. It will be conducted in two phases: first, adapting and validating the Geriatric Abuse Scale (GAS) for this specific patient population, and second, applying the validated scale to evaluate the extent of abuse and associated factors. The study addresses a significant gap in the literature regarding the vulnerability of patients with rheumatic diseases to abuse, given their chronic and progressive conditions.
Who should consider this trial
Good fit: Ideal candidates for this study are adults diagnosed with a rheumatic disease who consent to participate.
Not a fit: Patients without a confirmed diagnosis of a rheumatic disease will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved awareness and interventions for preventing abuse in patients with rheumatic diseases.
How similar studies have performed: While there is limited information on abuse prevalence in rheumatic disease patients, similar studies in older adults have shown significant findings, indicating potential relevance.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a rheumatic disease diagnosis according to their primary rheumatologist who agree to participate Exclusion Criteria: * Patients with a not confirmed rheumatic disease
Where this trial is running
Mexico City
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán — Mexico City, Mexico (Recruiting)
Study contacts
- Principal investigator: Virginia Dr Pascual-Ramos — Innsz
- Study coordinator: Virginia Ph Pascual-Ramos
- Email: virtichu@gmail.com
- Phone: 525555734111
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.